zonisamide has been researched along with Hamartoma in 1 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
Hamartoma: A focal malformation resembling a neoplasm, composed of an overgrowth of mature cells and tissues that normally occur in the affected area.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arita, K | 1 |
| Kurisu, K | 1 |
| Iida, K | 1 |
| Hanaya, R | 1 |
| Akimitsu, T | 1 |
| Hibino, S | 1 |
| Pant, B | 1 |
| Hamasaki, M | 1 |
| Shinagawa, S | 1 |
1 other study available for zonisamide and Hamartoma
| Article | Year |
|---|---|
Subsidence of seizure induced by stereotactic radiation in a patient with hypothalamic hamartoma. Case report.
Topics: Adult; Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsy, Temporal Lobe; Epilepsy, To | 1998 |